Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Blood|April 17, 2009
Phase 3 study of dasatinib 140 mg once daily versus 70 mg twice daily in patients with chronic myeloid leukemia in accelerated phase resistant or intolerant to imatinib: 15-month median follow-upHagop Kantarjian, Jorge Cortes, Dong-Wook Kim, et al.
Leukemia Research|August 10, 2016
Phase I study of azacitidine following donor lymphocyte infusion for relapsed acute myeloid leukemia post allogeneic stem cell transplantationArmin Ghobadi, Jaebok Choi, Mark A Fiala, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 22, 2013
Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendationsSergio Giralt, Luciano Costa, Jeffrey Schriber, et al.
Cancer|March 15, 2006
Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized studyHagop Kantarjian, Jean-Pierre J Issa, Craig S Rosenfeld, et al.
Blood|November 18, 2006
A phase 2/3 multicenter randomized clinical trial of ABX-CBL versus ATG as secondary therapy for steroid-resistant acute graft-versus-host diseaseMargaret L Macmillan, Daniel Couriel, Daniel J Weisdorf, et al.
Science Translational Medicine|January 17, 2020
Engraftment of rare, pathogenic donor hematopoietic mutations in unrelated hematopoietic stem cell transplantationWing Hing Wong, Sima Bhatt, Kathryn Trinkaus, et al.
Blood Cancer Discovery|January 12, 2022
Genetic and Transcriptional Contributions to Relapse in Normal Karyotype Acute Myeloid LeukemiaAllegra A Petti, Saad M Khan, Ziheng Xu, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2026
Defining the RNA Modification Landscape of Multiple Myeloma Reveals METTL3-Dependent m 6 A Regulation of NEAT1Prasanth Thunuguntla, Dhanusha Duraiyan, Catheryn Sizemore, et al.
Transplantation and Cellular Therapy|October 14, 2021
Upfront Alternative Donor Transplant versus Immunosuppressive Therapy in Patients with Severe Aplastic Anemia Who Lack a Fully HLA-Matched Related Donor: Systematic Review and Meta-Analysis of Retrospective Studies, on Behalf of the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow TransplantationHind Alotaibi, Mahmoud Aljurf, Regis de Latour, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 25, 2003
Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseasesRichard A Nash, Roger Dansey, Jan Storek, et al.
Pageof 5